Quick answers
- What is Ethiodized oil used for?
- The FDA-approved label (Lipiodol, Guerbet LLC, December 16, 2025) says: “Lipiodol is an oil-based radio-opaque contrast agent indicated for: hysterosalpingography in adults lymphography in adult and pediatric patients selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC) Lipiodol is an oil-based radiopaque contrast agent indicated for …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Ethiodized oil have a boxed warning?
- Yes. The FDA label for Lipiodol has a boxed warning (“WARNING: FOR INTRALYMPHATIC, INTRAUTERINE AND SELECTIVE HEPATIC INTRA-ARTERIAL USE ONLY”), the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Ethiodized oil?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Ethiodized oil been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Ethiodized oil?
- 1 company lists prescription products of Ethiodized oil in the FDA NDC Directory, including Guerbet LLC.
What Ethiodized oil is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Lipiodol is an oil-based radio-opaque contrast agent indicated for: hysterosalpingography in adults lymphography in adult and pediatric patients selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC) Lipiodol is an oil-based radiopaque contrast agent indicated for …
— FDA label: Lipiodol, Guerbet LLC, effective December 16, 2025. Read the full label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Its heading: WARNING: FOR INTRALYMPHATIC, INTRAUTERINE AND SELECTIVE HEPATIC INTRA-ARTERIAL USE ONLY
. Read it on the full label →
Forms and how it is given
| Dosage forms | Injection |
|---|---|
| Route | Intra-arterial · Intralymphatic · Intrauterine |
| Prescription products | 1 in the FDA NDC Directory |
| Brand names | Lipiodol |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Guerbet LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA009190 LIPIODOL | Guerbet | March 31, 1954 | 11, latest April 5, 2023 2023: Labeling · 2020: Labeling · 2020: Labeling |
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| SPL set ID of the quoted label | 511d1f64-5cb9-4baa-a123-96205467e59a |
|---|---|
| FDA labels (SPL) | 1 |
| FDA applications | NDA009190 |
| Active ingredients (FDA) | ETHIODIZED OIL |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Lipiodol, Guerbet LLC, effective December 16, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →